Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dr. Reddy's Acquires Dow's Small Molecules Business | Contract Pharma

What are you searching for?

Sign in
Breaking News

Dr. Reddy’s Acquires Dow’s Small Molecules Business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

In a busy week for Dr. Reddy’s Laboratories, the company has completed its acquisition of The Dow Chemical Company’s Dowpharma Small Molecules Business along with its Mirfield and Cambridge, UK sites. Financial terms of the transaction were not disclosed.
   
The acquisition includes the relevant business, customer contracts, associated products, process technology, intellectual property and trademarks, as well as the transfer of the Mirfield and Cambridge facilities. Employees directly related to the business at each site will become part of Dr Reddy’s. Dr. Reddy’s will also have a non-exclusive license to Dow’s Pfenex Expression Technology for biocatalysis development.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters